A successful case of extracorporeal membrane oxygenation treatment for intractable pneumothorax in a patient with COVID‐19
| Autor: | Nao Urushibata, Keita Nakatsutsumi, Tatsuki Fujiwara, Marie Hosoi, Kosuke Sekiya, Eiki Nagaoka, Yasuhiro Otomo, Junichi Aiboshi, Koji Morishita, Hirokuni Arai |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) pneumothorax medicine.medical_treatment Case Report Case presentation 03 medical and health sciences 0302 clinical medicine COVID‐19 medicine Extracorporeal membrane oxygenation 030212 general & internal medicine Thoracotomy Respiratory system Bulla (seal) Lung Acute respiratory distress syndrome business.industry General Engineering respiratory system extracorporeal membrane oxygenation medicine.disease Surgery respiratory tract diseases surgical procedures operative medicine.anatomical_structure 030228 respiratory system Pneumothorax business aerosols |
| Zdroj: | Acute Medicine & Surgery |
| ISSN: | 2052-8817 |
| Popis: | The combination of extracorporeal membrane oxygenation with lung‐protective ventilation strategies could be a potential treatment option for intractable pneumothorax with coronavirus disease 2019 (COVID‐19) to avoid unnecessary surgical procedures and aerosol generation. Background Some patients with coronavirus disease 2019 (COVID‐19) develop pneumothorax. Tube thoracotomy and bulla resection could generate aerosols and cause virus transmission; the optimal treatment strategy remains unclear. Case Presentation A 57‐year‐old male was transferred as a severe COVID‐19 pneumonia case. On the 16th day after admission, the patient’s respiratory condition deteriorated, and the chest X‐ray revealed the presence of severe right‐sided pneumothorax. A chest drain was immediately inserted; however, a significant air leak continued, and severe ventilator settings were required. Thus, veno‐venous extracorporeal membrane oxygenation (VV‐ECMO) treatment was initiated to allow the lungs to rest. After 10 days of lung‐protective ventilation, the patient was weaned from ECMO and the chest drain was removed on the following day with no major comorbidities. Conclusion The combination of ECMO with lung rest strategy could be a treatment option for intractable pneumothorax with COVID‐19 to avoid unnecessary surgical procedures and aerosol generation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text